chrX-153694800-A-G

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_005629.4(SLC6A8):ā€‹c.1678A>Gā€‹(p.Met560Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000886 in 1,209,092 control chromosomes in the GnomAD database, including 6 homozygotes. There are 537 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.00050 ( 1 hom., 27 hem., cov: 25)
Exomes š‘“: 0.00093 ( 5 hom. 510 hem. )

Consequence

SLC6A8
NM_005629.4 missense

Scores

1
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.0700
Variant links:
Genes affected
SLC6A8 (HGNC:11055): (solute carrier family 6 member 8) The protein encoded by this gene is a plasma membrane protein whose function is to transport creatine into and out of cells. Defects in this gene can result in X-linked creatine deficiency syndrome. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009688646).
BP6
Variant X-153694800-A-G is Benign according to our data. Variant chrX-153694800-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 378616.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-153694800-A-G is described in Lovd as [Likely_benign]. Variant chrX-153694800-A-G is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.000496 (56/112909) while in subpopulation SAS AF= 0.00936 (26/2777). AF 95% confidence interval is 0.00656. There are 1 homozygotes in gnomad4. There are 27 alleles in male gnomad4 subpopulation. Median coverage is 25. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 27 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SLC6A8NM_005629.4 linkc.1678A>G p.Met560Val missense_variant 12/13 ENST00000253122.10 NP_005620.1 P48029-1X5D9C4
SLC6A8NM_001142805.2 linkc.1648A>G p.Met550Val missense_variant 12/13 NP_001136277.1 P48029Q59EV7
SLC6A8NM_001142806.1 linkc.1333A>G p.Met445Val missense_variant 12/13 NP_001136278.1 P48029-4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SLC6A8ENST00000253122.10 linkc.1678A>G p.Met560Val missense_variant 12/131 NM_005629.4 ENSP00000253122.5 P48029-1
SLC6A8ENST00000430077.6 linkc.1333A>G p.Met445Val missense_variant 12/132 ENSP00000403041.2 P48029-4
SLC6A8ENST00000485324.1 linkn.1985A>G non_coding_transcript_exon_variant 5/62

Frequencies

GnomAD3 genomes
AF:
0.000487
AC:
55
AN:
112858
Hom.:
1
Cov.:
25
AF XY:
0.000742
AC XY:
26
AN XY:
35042
show subpopulations
Gnomad AFR
AF:
0.0000643
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000926
Gnomad ASJ
AF:
0.000754
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00897
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0126
Gnomad NFE
AF:
0.000319
Gnomad OTH
AF:
0.00330
GnomAD3 exomes
AF:
0.00160
AC:
291
AN:
181402
Hom.:
2
AF XY:
0.00277
AC XY:
185
AN XY:
66818
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000256
Gnomad ASJ exome
AF:
0.000135
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0125
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000458
Gnomad OTH exome
AF:
0.00223
GnomAD4 exome
AF:
0.000926
AC:
1015
AN:
1096183
Hom.:
5
Cov.:
37
AF XY:
0.00141
AC XY:
510
AN XY:
362125
show subpopulations
Gnomad4 AFR exome
AF:
0.000531
Gnomad4 AMR exome
AF:
0.000284
Gnomad4 ASJ exome
AF:
0.0000516
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0118
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000308
Gnomad4 OTH exome
AF:
0.00152
GnomAD4 genome
AF:
0.000496
AC:
56
AN:
112909
Hom.:
1
Cov.:
25
AF XY:
0.000769
AC XY:
27
AN XY:
35103
show subpopulations
Gnomad4 AFR
AF:
0.0000642
Gnomad4 AMR
AF:
0.0000925
Gnomad4 ASJ
AF:
0.000754
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00936
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000319
Gnomad4 OTH
AF:
0.00326
Alfa
AF:
0.000669
Hom.:
5
Bravo
AF:
0.000321
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000446
AC:
3
ExAC
AF:
0.00199
AC:
241
EpiCase
AF:
0.000763
EpiControl
AF:
0.000951

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxAug 15, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Likely benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpMay 03, 2022- -
Creatine transporter deficiency Benign:2
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -
Benign, criteria provided, single submitterresearchBroad Center for Mendelian Genomics, Broad Institute of MIT and Harvard-The p.Met560Val variant in SLC6A8 has been identified in at least 1 individual with creatine deficiency (PMID: 20717164), but has also been identified in >1% of South Asian chromosomes, 88 hemizygotes, and 1 homozygote by ExAC (http://gnomad.broadinstitute.org/). In summary, this variant meets criteria to be classified as benign for X-linked recessive creatine deficiency. -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsJan 27, 2017This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
not provided Benign:1
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.052
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.30
CADD
Benign
7.4
DANN
Benign
0.67
DEOGEN2
Benign
0.083
T;.
FATHMM_MKL
Benign
0.57
D
LIST_S2
Benign
0.81
T;T
MetaRNN
Benign
0.0097
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-1.1
N;.
PrimateAI
Benign
0.28
T
PROVEAN
Benign
0.88
N;N
REVEL
Uncertain
0.37
Sift
Benign
0.49
T;T
Sift4G
Benign
0.45
T;T
Polyphen
0.0
B;.
Vest4
0.055
MVP
0.95
MPC
0.15
ClinPred
0.0094
T
GERP RS
1.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.087
gMVP
0.60

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs145438966; hg19: chrX-152960255; API